Clostridioides Difficile Prevention: Quality Strategies for Reducing C. diff Infections
Understanding C. diff Infection
Clostridioides difficile (C. diff) infection (CDI) is a significant healthcare-associated infection that causes diarrhea, colitis, and in severe cases, death. C. diff forms spores that are resistant to alcohol-based hand sanitizers and can persist in the environment for extended periods. The primary risk factor for CDI is antibiotic exposure, which disrupts normal gut flora and allows C. diff to proliferate. CMS includes CDI in its Hospital-Acquired Condition Reduction Program and requires reporting through NHSN. Quality professionals must understand CDI epidemiology, prevention strategies, and reporting requirements as part of comprehensive infection prevention knowledge.
Antibiotic Stewardship and CDI Prevention
Because antibiotic exposure is the most significant modifiable risk factor for CDI, antimicrobial stewardship programs are the cornerstone of prevention. Reducing unnecessary antibiotic use, selecting narrow-spectrum agents when appropriate, limiting antibiotic duration, and avoiding high-risk antibiotic classes (such as fluoroquinolones and clindamycin when alternatives are available) all contribute to CDI risk reduction. Quality professionals collaborate with antimicrobial stewardship teams to track antibiotic use patterns, correlate prescribing trends with CDI rates, and develop targeted interventions for units or patient populations with high CDI incidence.
Environmental Cleaning and Disinfection
C. diff spores are resistant to many commonly used hospital disinfectants, including quaternary ammonium compounds. Effective environmental cleaning for C. diff requires the use of sporicidal disinfectants, such as bleach-based products or EPA-registered sporicidal agents. Enhanced cleaning protocols for rooms of patients with CDI include increased cleaning frequency, targeted cleaning of high-touch surfaces, and terminal cleaning with sporicidal agents upon patient discharge. Some organizations supplement manual cleaning with ultraviolet (UV) light disinfection or hydrogen peroxide vapor technology. Quality professionals monitor compliance with environmental cleaning protocols and track the relationship between cleaning practices and CDI rates.
Contact Precautions and Hand Hygiene
Patients with CDI should be placed on contact precautions, which include the use of gowns and gloves for all patient contact and dedicated patient care equipment. Because C. diff spores are not killed by alcohol-based hand sanitizers, handwashing with soap and water is recommended after caring for patients with CDI. The CDC recommends that healthcare workers caring for CDI patients preferentially use soap and water for hand hygiene. Quality professionals reinforce these practices through education, signage, and compliance monitoring to reduce the risk of patient-to-patient transmission.
Surveillance and Reporting
CDI surveillance follows NHSN definitions, which categorize infections based on the timing and location of symptom onset. Healthcare facility-onset (HO) CDI, where symptoms develop on or after hospital day four, is attributed to the facility. Community-onset healthcare facility-associated (CO-HCFA) CDI captures infections that develop in the community but are linked to a recent hospitalization. The standardized infection ratio (SIR) compares observed CDI rates to expected rates based on facility characteristics. Quality professionals ensure accurate surveillance, investigate facility-onset cases for preventable contributing factors, and report data through required channels to CMS.